tiprankstipranks
Trending News
More News >
Fmc Corp. (FMC)
NYSE:FMC
US Market

FMC (FMC) Earnings Dates, Call Summary & Reports

Compare
1,431 Followers

Earnings Data

Report Date
Aug 05, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.61
Last Year’s EPS
0.63
Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Apr 30, 2025
|
% Change Since: -4.53%
|
Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with notable progress in strategic initiatives and a positive outlook for the second half of 2025, driven by new product launches and market expansions. However, the company faced significant challenges in Q1 with sales declines, tariff impacts, and regional performance issues, particularly in North America, Asia, and EMEA.
Company Guidance
During the First Quarter 2025 Earnings Call for FMC Corporation, the company provided guidance indicating a positive outlook for the second half of the year despite some early challenges. The company anticipates a revenue decline of 2% in the second quarter, with lower pricing and a foreign exchange headwind, but expects growth in the second half driven by cost favorability and new product sales. Specifically, full-year sales are expected to be flat, with adjusted EBITDA projected to grow 1% and adjusted earnings per share remaining flat. The call highlighted strategic efforts, such as reducing channel inventory, implementing a post-patent strategy, and establishing a new route to market in Brazil. The latter is expected to capitalize on a multi-hundred million dollar growth opportunity by selling directly to large corn and soybean growers. Additionally, significant growth is anticipated from new products like Rynaxypyr mixtures, with sales projected to reach $200 million to $250 million in 2025. Despite facing a $15 million to $20 million cost headwind from tariffs, the company remains confident in its ability to achieve its financial targets for 2025.
Strong Progress in Key Focus Areas
FMC made significant advancements in four critical focus areas: aligning channel inventory levels, implementing a post-patent strategy, establishing a new route to market in Brazil, and ensuring resources for the growth portfolio, particularly with Rynaxypyr.
New Product Launches and Market Expansion
FMC introduced new formulations of Rynaxypyr and Bifenthrin, with expected sales of $200-$250 million in 2025. Additionally, the company is launching new products in Brazil, targeting large corn and soybean growers, expected to provide a multi-hundred million dollar growth opportunity.
Growth in Plant Health Segment
The Plant Health business outperformed the portfolio with sales up 1% versus the prior year, driven by biologicals. The recent registration of Sofero pheromone in Brazil is expected to boost sales further.
Positive Outlook for Second Half of 2025
FMC expects strong growth in the second half of 2025, driven by new products, a new route to market in Brazil, and improved channel inventory levels. The company anticipates a revenue growth of 7% and EBITDA growth of 11% in the second half.
---

FMC (FMC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

FMC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 05, 2025
2025 (Q2)
0.61 / -
0.63
Apr 30, 2025
2025 (Q1)
0.09 / 0.18
0.36-50.00% (-0.18)
Feb 04, 2025
2024 (Q4)
1.60 / 1.79
1.0767.29% (+0.72)
Oct 29, 2024
2024 (Q3)
0.57 / 0.69
0.4456.82% (+0.25)
Jul 31, 2024
2024 (Q2)
0.55 / 0.63
0.526.00% (+0.13)
May 06, 2024
2024 (Q1)
0.32 / 0.36
1.77-79.66% (-1.41)
Feb 05, 2024
2023 (Q4)
1.08 / 1.07
2.37-54.85% (-1.30)
Oct 30, 2023
2023 (Q3)
0.54 / 0.44
1.23-64.23% (-0.79)
Aug 02, 2023
2023 (Q2)
0.61 / 0.50
1.93-74.09% (-1.43)
May 01, 2023
2023 (Q1)
1.75 / 1.77
1.88-5.85% (-0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

FMC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2025
$41.92$38.45-8.28%
Feb 04, 2025
$53.30$35.43-33.53%
Oct 29, 2024
$58.64$64.92+10.71%
Jul 31, 2024
$56.37$62.14+10.24%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Fmc Corp. (FMC) report earnings?
Fmc Corp. (FMC) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
    What is Fmc Corp. (FMC) earnings time?
    Fmc Corp. (FMC) earnings time is at Aug 05, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is FMC EPS forecast?
          FMC EPS forecast for the fiscal quarter 2025 (Q2) is 0.61.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis